Similar articles

• Letter by Tsuda Regarding Article, "A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".

  Tsuda K. Tsuda K. Circulation. 2018 Mar 13;137(11):1198-1199. doi: 10.1161/CIRCULATIONAHA.117.030714. Circulation. 2018. PMID: 29530896 No abstract available.
• Letter by Jin-shan and Xue-bin Regarding Article, "A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".

  Jin-Shan H, Xue-Bin L. Jin-Shan H, et al. Circulation. 2018 Mar 13;137(11):1200. doi: 10.1161/CIRCULATIONAHA.117.031504. Circulation. 2018. PMID: 29530897 No abstract available.
• A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure.

  Aubdool AA, Thakore P, Argunhan F, Smillie SJ, Schnelle M, Srivastava S, Alawi KM, Wilde E, Mitchell J, Farrell-Dillon K, Richards DA, Maltese G, Siow RC, Nandi M, Clark JE, Shah AM, Sams A, Brain SD. Aubdool AA, et al. Circulation. 2017 Jul 25;136(4):367-383. doi: 10.1161/CIRCULATIONAHA.117.028388. Epub 2017 Apr 26. Circulation. 2017. PMID: 28446517 Free PMC article.
• Calcitonin gene-related peptide (CGRP) and hypertrophy of cardiomyocytes.

  Ito H, Bell D, Tamamori M, Nozato T, Shimojo T, Adachi S, Abe S, Marumo F, Hiroe M. Ito H, et al. Heart Vessels. 1997;Suppl 12:15-7. Heart Vessels. 1997. PMID: 9476534 Review.
• Role of angiotensin-converting enzyme inhibitors in preventing or reducing end-organ damage in hypertension.

  Doyle AE. Doyle AE. J Cardiovasc Pharmacol. 1992;19 Suppl 5:S21-7. J Cardiovasc Pharmacol. 1992. PMID: 1381791 Review.